[{"address1": "30 Technology Drive", "city": "Warren", "state": "NJ", "zip": "07059", "country": "United States", "phone": "908 941 1900", "website": "https://www.aquestive.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; KYNMOBI a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary pipeline products include Anaphylm, an epinephrine sublingual film, which is in phase 3 clinical trial for the emergency treatment of allergic reactions, including anaphylaxis; and AQST-108, a topical gel that is in phase 2 clinical trial for the treatment of alopecia areata. In addition, it develops PharmFilm technology for patients suffering from certain central nervous system disorders; and Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.", "fullTimeEmployees": 142, "companyOfficers": [{"maxAge": 1, "name": "Mr. Daniel  Barber", "age": 48, "title": "CEO, President & Director", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 1097468, "exercisedValue": 0, "unexercisedValue": 469825}, {"maxAge": 1, "name": "Ms. Lori J. Braender BSBA, Esq., J.D.", "age": 68, "title": "Chief Legal Officer, Chief Compliance Officer & Secretary", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 737771, "exercisedValue": 0, "unexercisedValue": 255600}, {"maxAge": 1, "name": "Mr. A. Ernest Toth Jr.", "age": 65, "title": "Chief Financial Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 667187, "exercisedValue": 0, "unexercisedValue": 11400}, {"maxAge": 1, "name": "Ms. Cassie  Jung", "age": 44, "title": "Chief Operating Officer", "yearBorn": 1980, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter E. Boyd", "age": 59, "title": "Senior Vice President of Information Technology & Chief People Officer", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gary H. Slatko M.D., MBA", "age": 67, "title": "Interim Chief Medical Officer", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sherry  Korczynski", "age": 54, "title": "Chief Commercial Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Melina T. Cioffi Pharm.D.", "age": 41, "title": "Senior Vice President of Regulatory Affairs", "yearBorn": 1983, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Matthew William Davis M.D., R.Ph.", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert Charles Arnold", "title": "VP of Finance, Controller & Assistant Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 6, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 5.97, "open": 6.0, "dayLow": 5.835, "dayHigh": 6.0499, "regularMarketPreviousClose": 5.97, "regularMarketOpen": 6.0, "regularMarketDayLow": 5.835, "regularMarketDayHigh": 6.0499, "payoutRatio": 0.0, "beta": 1.585, "forwardPE": -13.410347, "volume": 1651138, "regularMarketVolume": 1651138, "averageVolume": 2794275, "averageVolume10days": 2199670, "averageDailyVolume10Day": 2199670, "bid": 4.19, "ask": 5.76, "bidSize": 2, "askSize": 1, "marketCap": 730798592, "fiftyTwoWeekLow": 2.12, "fiftyTwoWeekHigh": 7.55, "allTimeHigh": 20.696, "allTimeLow": 0.618, "priceToSalesTrailing12Months": 16.839842, "fiftyDayAverage": 6.2229, "twoHundredDayAverage": 4.350975, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 643111616, "profitMargins": -1.58949, "floatShares": 111904915, "sharesOutstanding": 122003113, "sharesShort": 21919352, "sharesShortPriorMonth": 19196523, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.17969999, "heldPercentInsiders": 0.04062, "heldPercentInstitutions": 0.57013, "shortRatio": 8.88, "shortPercentOfFloat": 0.206, "impliedSharesOutstanding": 122003113, "bookValue": -0.034, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -68979000, "trailingEps": -0.7, "forwardEps": -0.44667, "enterpriseToRevenue": 14.819, "enterpriseToEbitda": -11.65, "52WeekChange": 0.69602275, "SandP52WeekChange": 0.17354333, "quoteType": "EQUITY", "currentPrice": 5.99, "targetHighPrice": 15.0, "targetLowPrice": 8.0, "targetMeanPrice": 10.55556, "targetMedianPrice": 11.0, "recommendationMean": 1.22222, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 9, "totalCash": 129063000, "totalCashPerShare": 1.058, "ebitda": -55203000, "totalDebt": 41376000, "quickRatio": 5.508, "currentRatio": 5.931, "totalRevenue": 43397000, "revenuePerShare": 0.437, "returnOnAssets": -0.25496998, "grossProfits": 26158000, "freeCashflow": -25766250, "operatingCashflow": -50452000, "revenueGrowth": -0.054, "grossMargins": 0.60276, "ebitdaMargins": -1.27205, "operatingMargins": -0.89631, "financialCurrency": "USD", "symbol": "AQST", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1532525400000, "postMarketChangePercent": 0.16694874, "postMarketPrice": 6.0, "postMarketChange": 0.010000229, "regularMarketChange": 0.02, "regularMarketDayRange": "5.835 - 6.0499", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 2794275, "fiftyTwoWeekLowChange": 3.87, "fiftyTwoWeekLowChangePercent": 1.8254718, "fiftyTwoWeekRange": "2.12 - 7.55", "fiftyTwoWeekHighChange": -1.5600004, "fiftyTwoWeekHighChangePercent": -0.20662257, "fiftyTwoWeekChangePercent": 69.60227, "corporateActions": [], "postMarketTime": 1766796812, "regularMarketTime": 1766782801, "exchange": "NGM", "messageBoardId": "finmb_8142504", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.335008, "regularMarketPrice": 5.99, "marketState": "CLOSED", "shortName": "Aquestive Therapeutics, Inc.", "longName": "Aquestive Therapeutics, Inc.", "earningsTimestamp": 1762376400, "earningsTimestampStart": 1762376400, "earningsTimestampEnd": 1762376400, "earningsCallTimestampStart": 1762434000, "earningsCallTimestampEnd": 1762434000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.7, "epsForward": -0.44667, "epsCurrentYear": -0.57333, "priceEpsCurrentYear": -10.447735, "fiftyDayAverageChange": -0.23290014, "fiftyDayAverageChangePercent": -0.037426304, "twoHundredDayAverageChange": 1.6390247, "twoHundredDayAverageChangePercent": 0.37670285, "priceToBook": -176.17645, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "displayName": "Aquestive Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-12-27"}]